subject area of
- 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis Journal Articles
- A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections Journal Articles
- A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics Journal Articles
- American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis Journal Articles
- An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab. Journal Articles
- Anti-TNFα therapy in immune-mediated subfertility: State of the art Journal Articles
- Anti-cytokine targeted therapies for ANCA-associated vasculitis Journal Articles
- Assessment of health‐related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's) Journal Articles
- Biologic survival. Journal Articles
- Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis. Journal Articles
- Community-based evaluation of etanercept in patients with rheumatoid arthritis. Journal Articles
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials Journal Articles
- Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis Journal Articles
- Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice Journal Articles
- Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab Journal Articles
- Immunotherapies in Dermatologic Disorders Journal Articles
- Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study. Journal Articles
- Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab Journal Articles
- Nail Psoriasis and Biologics Journal Articles
- One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population Journal Articles
- Patient outcomes after anti TNF-α drugs for Crohn’s disease Journal Articles
- Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics Journal Articles
- Response times follow lognormal or gamma distribution in arthritis patients Journal Articles
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Journal Articles
- TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial Journal Articles
- Targeting Genes for Treatment in Idiopathic Pulmonary Fibrosis: Challenges and Opportunities, Promises and Pitfalls Journal Articles
- Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease Journal Articles
- Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis Journal Articles
- Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis Journal Articles